Published in J Am Heart Assoc on October 08, 2013
Mitochondrial fission and fusion factors reciprocally orchestrate mitophagic culling in mouse hearts and cultured fibroblasts. Cell Metab (2015) 1.43
Inhibition of dynamin-related protein 1 protects against myocardial ischemia-reperfusion injury in diabetic mice. Cardiovasc Diabetol (2017) 1.39
The mitochondrial dynamism-mitophagy-cell death interactome: multiple roles performed by members of a mitochondrial molecular ensemble. Circ Res (2014) 1.18
Mitochondrial fusion and fission proteins: novel therapeutic targets for combating cardiovascular disease. Br J Pharmacol (2014) 1.04
Mitoconfusion: noncanonical functioning of dynamism factors in static mitochondria of the heart. Cell Metab (2015) 1.02
Mitochondrial reactive oxygen species at the heart of the matter: new therapeutic approaches for cardiovascular diseases. Circ Res (2015) 1.02
How mitochondrial dynamism orchestrates mitophagy. Circ Res (2015) 0.98
Mitochondrial dynamism and heart disease: changing shape and shaping change. EMBO Mol Med (2015) 0.89
Gone fission…: diverse consequences of cardiac Drp1 deficiency. Circ Res (2015) 0.88
Molecular mechanisms mediating mitochondrial dynamics and mitophagy and their functional roles in the cardiovascular system. J Mol Cell Cardiol (2014) 0.86
Mitochondrial fusion and fission proteins as novel therapeutic targets for treating cardiovascular disease. Eur J Pharmacol (2015) 0.85
Autophagy, Innate Immunity and Tissue Repair in Acute Kidney Injury. Int J Mol Sci (2016) 0.84
The role of hexokinase in cardioprotection - mechanism and potential for translation. Br J Pharmacol (2014) 0.84
MiRNA-30a inhibits AECs-II apoptosis by blocking mitochondrial fission dependent on Drp-1. J Cell Mol Med (2014) 0.84
Inhibition of the mitochondrial fission protein dynamin-related protein 1 improves survival in a murine cardiac arrest model. Crit Care Med (2015) 0.83
Aldehydic load and aldehyde dehydrogenase 2 profile during the progression of post-myocardial infarction cardiomyopathy: benefits of Alda-1. Int J Cardiol (2014) 0.82
Mitochondrial dynamics, mitophagy and cardiovascular disease. J Physiol (2016) 0.82
Inhibition of Drp1 mitochondrial translocation provides neural protection in dopaminergic system in a Parkinson's disease model induced by MPTP. Sci Rep (2016) 0.81
Dysregulation of Mfn2 and Drp-1 proteins in heart failure. Can J Physiol Pharmacol (2014) 0.81
Role of mitochondrial fission and fusion in cardiomyocyte contractility. Int J Cardiol (2015) 0.81
Chronology of mitochondrial and cellular events during skeletal muscle ischemia-reperfusion. Am J Physiol Cell Physiol (2016) 0.80
Resistance of Dynamin-related Protein 1 Oligomers to Disassembly Impairs Mitophagy, Resulting in Myocardial Inflammation and Heart Failure. J Biol Chem (2015) 0.80
Mitochondrial redox status as a target for cardiovascular disease. Curr Opin Pharmacol (2016) 0.79
Dynamin-related protein 1 as a therapeutic target in cardiac arrest. J Mol Med (Berl) (2015) 0.79
New therapeutics to modulate mitochondrial dynamics and mitophagy in cardiac diseases. J Mol Med (Berl) (2015) 0.79
The many hats of protein kinase Cδ: one enzyme with many functions. Biochem Soc Trans (2014) 0.79
Mff-Dependent Mitochondrial Fission Contributes to the Pathogenesis of Cardiac Microvasculature Ischemia/Reperfusion Injury via Induction of mROS-Mediated Cardiolipin Oxidation and HK2/VDAC1 Disassociation-Involved mPTP Opening. J Am Heart Assoc (2017) 0.78
Hearts deficient in both Mfn1 and Mfn2 are protected against acute myocardial infarction. Cell Death Dis (2016) 0.77
Mitochondrial remodeling: Rearranging, recycling, and reprogramming. Cell Calcium (2016) 0.77
Flicker-assisted localization microscopy reveals altered mitochondrial architecture in hypertension. Sci Rep (2015) 0.77
Transient Receptor Potential Vanilloid 1 Regulates Mitochondrial Membrane Potential and Myocardial Reperfusion Injury. J Am Heart Assoc (2016) 0.77
Mitochondrial Quality Control and Disease: Insights into Ischemia-Reperfusion Injury. Mol Neurobiol (2017) 0.76
Disabling mitochondrial reprogramming in cancer. Pharmacol Res (2015) 0.76
Sevoflurane postconditioning attenuates cardiomyocyte hypoxia/reoxygenation injury via restoring mitochondrial morphology. PeerJ (2016) 0.76
Vagal nerve stimulation improves mitochondrial dynamics via an M3 receptor/CaMKKβ/AMPK pathway in isoproterenol-induced myocardial ischaemia. J Cell Mol Med (2016) 0.75
Disruption of mitochondrial quality control in peripheral artery disease: New therapeutic opportunities. Pharmacol Res (2016) 0.75
Afzelin ameliorates D-galactosamine and lipopolysaccharide-induced fulminant hepatic failure by modulating mitochondrial quality control and dynamics (150/150). Br J Pharmacol (2016) 0.75
Pim-1 Kinase Regulating Dynamics Related Protein 1 Mediates Sevoflurane Postconditioning-induced Cardioprotection. Chin Med J (Engl) (2017) 0.75
Potential biomarkers to follow the progression and treatment response of Huntington's disease. J Exp Med (2016) 0.75
Nat1 Deficiency Is Associated with Mitochondrial Dysfunction and Exercise Intolerance in Mice. Cell Rep (2016) 0.75
Mitochondrial-Shaping Proteins in Cardiac Health and Disease - the Long and the Short of It! Cardiovasc Drugs Ther (2017) 0.75
Increase in Cardiac Ischemia-Reperfusion Injuries in Opa1+/- Mouse Model. PLoS One (2016) 0.75
Inhibition of Drp1 hyper-activation is protective in animal models of experimental multiple sclerosis. Exp Neurol (2017) 0.75
Recent advances in mitochondrial research. Circ Res (2013) 0.75
Ischemia-induced Drp1 and Fis1-mediated mitochondrial fission and right ventricular dysfunction in pulmonary hypertension. J Mol Med (Berl) (2017) 0.75
Mitochondrial fission/fusion and cardiomyopathy. Curr Opin Genet Dev (2016) 0.75
Mitochondrial Quality Control in Cardiac Diseases. Front Physiol (2016) 0.75
LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J (2000) 41.48
Fission and selective fusion govern mitochondrial segregation and elimination by autophagy. EMBO J (2008) 12.89
The role of dynamin-related protein 1, a mediator of mitochondrial fission, in apoptosis. Dev Cell (2001) 10.33
Selective degradation of mitochondria by mitophagy. Arch Biochem Biophys (2007) 8.24
Functions and dysfunctions of mitochondrial dynamics. Nat Rev Mol Cell Biol (2007) 6.33
Chemical inhibition of the mitochondrial division dynamin reveals its role in Bax/Bak-dependent mitochondrial outer membrane permeabilization. Dev Cell (2008) 5.67
The mitochondrial permeability transition initiates autophagy in rat hepatocytes. FASEB J (2001) 4.99
The mitochondrial protein hFis1 regulates mitochondrial fission in mammalian cells through an interaction with the dynamin-like protein DLP1. Mol Cell Biol (2003) 4.56
Mff is an essential factor for mitochondrial recruitment of Drp1 during mitochondrial fission in mammalian cells. J Cell Biol (2010) 3.91
Inhibiting mitochondrial fission protects the heart against ischemia/reperfusion injury. Circulation (2010) 3.72
Mitochondrial dysfunction in cardiac disease: ischemia--reperfusion, aging, and heart failure. J Mol Cell Cardiol (2001) 3.01
Impairing the bioenergetic status and the biogenesis of mitochondria triggers mitophagy in yeast. Cell Death Differ (2005) 2.73
Human MIEF1 recruits Drp1 to mitochondrial outer membranes and promotes mitochondrial fusion rather than fission. EMBO J (2011) 2.71
Mitochondrial fusion, fission and autophagy as a quality control axis: the bioenergetic view. Biochim Biophys Acta (2008) 2.56
H(2)O(2) regulates cardiac myocyte phenotype via concentration-dependent activation of distinct kinase pathways. J Mol Cell Cardiol (2003) 2.31
Mitochondrial fission proteins regulate programmed cell death in yeast. Genes Dev (2004) 2.30
Mitochondrial fusion is essential for organelle function and cardiac homeostasis. Circ Res (2011) 2.27
MiD49 and MiD51, new components of the mitochondrial fission machinery. EMBO Rep (2011) 2.26
Inhibition of delta-protein kinase C protects against reperfusion injury of the ischemic heart in vivo. Circulation (2003) 1.80
Mitochondria in heart failure. Cardiovasc Res (2010) 1.75
Tissue-, substrate-, and site-specific characteristics of mitochondrial reactive oxygen species generation. Free Radic Biol Med (2009) 1.72
Molecular transporters for peptides: delivery of a cardioprotective epsilonPKC agonist peptide into cells and intact ischemic heart using a transport system, R(7). Chem Biol (2001) 1.58
Mitochondrial dynamics in mammals. Curr Top Dev Biol (2004) 1.53
Mitochondrial morphology and cardiovascular disease. Cardiovasc Res (2010) 1.51
Morphological dynamics of mitochondria--a special emphasis on cardiac muscle cells. J Mol Cell Cardiol (2009) 1.48
The mitochondrial permeability transition pore: its fundamental role in mediating cell death during ischaemia and reperfusion. J Mol Cell Cardiol (2003) 1.44
Time-dependent and ethanol-induced cardiac protection from ischemia mediated by mitochondrial translocation of varepsilonPKC and activation of aldehyde dehydrogenase 2. J Mol Cell Cardiol (2008) 1.44
Mitochondria as a source of reactive oxygen and nitrogen species: from molecular mechanisms to human health. Antioxid Redox Signal (2013) 1.43
A novel Drp1 inhibitor diminishes aberrant mitochondrial fission and neurotoxicity. J Cell Sci (2012) 1.42
Identification of a novel mitochondrial complex containing mitofusin 2 and stomatin-like protein 2. J Biol Chem (2006) 1.36
Mitochondrial import of PKCepsilon is mediated by HSP90: a role in cardioprotection from ischaemia and reperfusion injury. Cardiovasc Res (2010) 1.30
Novel structure of the N terminus in yeast Fis1 correlates with a specialized function in mitochondrial fission. J Biol Chem (2005) 1.27
What can mitochondrial heterogeneity tell us about mitochondrial dynamics and autophagy? Int J Biochem Cell Biol (2009) 1.23
Mitochondria and reperfusion injury of the heart--a holey death but not beyond salvation. J Bioenerg Biomembr (2009) 1.23
Possible division of cardiac mitochondria. Anat Rec (1972) 1.18
Mitochondrial dynamics in cardiovascular health and disease. Antioxid Redox Signal (2012) 1.17
Proapoptotic BCL-2 family members and mitochondrial dysfunction during ischemia/reperfusion injury, a study employing cardiac HL-1 cells and GFP biosensors. Biochim Biophys Acta (2006) 1.06
Exercise training restores cardiac protein quality control in heart failure. PLoS One (2012) 1.06
A selective inhibitor of Drp1, mdivi-1, acts against cerebral ischemia/reperfusion injury via an anti-apoptotic pathway in rats. Neurosci Lett (2013) 0.97
Resveratrol inhibits MAPK activity and nuclear translocation in coronary artery smooth muscle: reversal of endothelin-1 stimulatory effects. FEBS Lett (1999) 0.97
The actions of mdivi-1, an inhibitor of mitochondrial fission, on rapidly activating delayed-rectifier K⁺ current and membrane potential in HL-1 murine atrial cardiomyocytes. Eur J Pharmacol (2012) 0.96
Assessing mitochondrial morphology and dynamics using fluorescence wide-field microscopy and 3D image processing. Methods (2008) 0.95
Mitochondrial dysfunction in heart failure: potential for therapeutic interventions? Cardiovasc Res (2000) 0.93
Mitochondrial dynamism and cardiac fate--a personal perspective. Circ J (2013) 0.91
Reproducible and uniform cardiac ischemia: effects of antiarrhythmic drugs. Am J Physiol (1978) 0.80
Activation of aldehyde dehydrogenase-2 reduces ischemic damage to the heart. Science (2008) 4.32
Intracoronary KAI-9803 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction. Circulation (2008) 2.59
The N-end rule pathway as a nitric oxide sensor controlling the levels of multiple regulators. Nature (2005) 2.55
Inhibition of mitochondrial fragmentation diminishes Huntington's disease-associated neurodegeneration. J Clin Invest (2013) 1.83
Aldehyde dehydrogenase activation prevents reperfusion arrhythmias by inhibiting local renin release from cardiac mast cells. Circulation (2010) 1.82
Serum and urine metabolite profiling reveals potential biomarkers of human hepatocellular carcinoma. Mol Cell Proteomics (2011) 1.81
Inhibition of delta-protein kinase C protects against reperfusion injury of the ischemic heart in vivo. Circulation (2003) 1.80
Pharmacological inhibition of epsilon PKC suppresses chronic inflammation in murine cardiac transplantation model. J Mol Cell Cardiol (2007) 1.78
Protein kinase C delta mediates cerebral reperfusion injury in vivo. J Neurosci (2004) 1.71
Impaired perfusion after myocardial infarction is due to reperfusion-induced deltaPKC-mediated myocardial damage. Cardiovasc Res (2006) 1.70
Preservation of base-line hemodynamic function and loss of inducible cardioprotection in adult mice lacking protein kinase C epsilon. J Biol Chem (2003) 1.63
Protein kinase Cdelta activation induces apoptosis in response to cardiac ischemia and reperfusion damage: a mechanism involving BAD and the mitochondria. J Biol Chem (2004) 1.62
Additive protection of the ischemic heart ex vivo by combined treatment with delta-protein kinase C inhibitor and epsilon-protein kinase C activator. Circulation (2003) 1.60
Cardioprotection by epsilon-protein kinase C activation from ischemia: continuous delivery and antiarrhythmic effect of an epsilon-protein kinase C-activating peptide. Circulation (2004) 1.60
Alda-1 is an agonist and chemical chaperone for the common human aldehyde dehydrogenase 2 variant. Nat Struct Mol Biol (2010) 1.57
PKC isozymes in chronic cardiac disease: possible therapeutic targets? Annu Rev Pharmacol Toxicol (2008) 1.51
Targeting aldehyde dehydrogenase 2: new therapeutic opportunities. Physiol Rev (2014) 1.51
Protein kinase C in heart failure: a therapeutic target? Cardiovasc Res (2009) 1.50
Epsilon PKC is required for the induction of tolerance by ischemic and NMDA-mediated preconditioning in the organotypic hippocampal slice. J Neurosci (2003) 1.50
Aberrant mitochondrial fission in neurons induced by protein kinase C{delta} under oxidative stress conditions in vivo. Mol Biol Cell (2010) 1.49
Inhibition of excessive mitochondrial fission reduced aberrant autophagy and neuronal damage caused by LRRK2 G2019S mutation. Hum Mol Genet (2013) 1.47
Cardioprotection mediated by sphingosine-1-phosphate and ganglioside GM-1 in wild-type and PKC epsilon knockout mouse hearts. Am J Physiol Heart Circ Physiol (2002) 1.45
Dopamine-induced exocytosis of Na,K-ATPase is dependent on activation of protein kinase C-epsilon and -delta. Mol Biol Cell (2002) 1.45
Time-dependent and ethanol-induced cardiac protection from ischemia mediated by mitochondrial translocation of varepsilonPKC and activation of aldehyde dehydrogenase 2. J Mol Cell Cardiol (2008) 1.44
The role of protein kinase C in cerebral ischemic and reperfusion injury. Stroke (2005) 1.44
Mitochondria as a source of reactive oxygen and nitrogen species: from molecular mechanisms to human health. Antioxid Redox Signal (2013) 1.43
A novel Drp1 inhibitor diminishes aberrant mitochondrial fission and neurotoxicity. J Cell Sci (2012) 1.42
Cardioprotective mechanisms of PKC isozyme-selective activators and inhibitors in the treatment of ischemia-reperfusion injury. Pharmacol Res (2007) 1.41
Mitochondrial aldehyde dehydrogenase and cardiac diseases. Cardiovasc Res (2010) 1.39
Aldehyde dehydrogenase 2 in cardiac protection: a new therapeutic target? Trends Cardiovasc Med (2009) 1.38
Opposing roles of delta and epsilonPKC in cardiac ischemia and reperfusion: targeting the apoptotic machinery. Arch Biochem Biophys (2003) 1.37
Epsilon protein kinase C as a potential therapeutic target for the ischemic heart. Cardiovasc Res (2006) 1.35
Reperfusion-induced translocation of deltaPKC to cardiac mitochondria prevents pyruvate dehydrogenase reactivation. Circ Res (2005) 1.34
Cardiopulmonary manifestations of hepatosplenic schistosomiasis. Circulation (2009) 1.30
Mitochondrial import of PKCepsilon is mediated by HSP90: a role in cardioprotection from ischaemia and reperfusion injury. Cardiovasc Res (2010) 1.30
Activation of aldehyde dehydrogenase 2 (ALDH2) confers cardioprotection in protein kinase C epsilon (PKCvarepsilon) knockout mice. J Mol Cell Cardiol (2009) 1.27
The PKCdelta -Abl complex communicates ER stress to the mitochondria - an essential step in subsequent apoptosis. J Cell Sci (2008) 1.26
A distinct translation initiation mechanism generates cryptic peptides for immune surveillance. PLoS One (2008) 1.26
Intracellular transport mechanisms of signal transducers. Annu Rev Physiol (2002) 1.26
The betagamma subunit of heterotrimeric G proteins interacts with RACK1 and two other WD repeat proteins. J Biol Chem (2002) 1.24
Biodistribution of intracellularly acting peptides conjugated reversibly to Tat. Biochem Biophys Res Commun (2004) 1.22
Tissue angiotensin II during progression or ventricular hypertrophy to heart failure in hypertensive rats; differential effects on PKC epsilon and PKC beta. J Mol Cell Cardiol (2002) 1.20
Ischaemic preconditioning improves proteasomal activity and increases the degradation of deltaPKC during reperfusion. Cardiovasc Res (2009) 1.18
Rationally designed peptide regulators of protein kinase C. Trends Endocrinol Metab (2008) 1.17
Suppression of deltaPKC activation after focal cerebral ischemia contributes to the protective effect of hypothermia. J Cereb Blood Flow Metab (2007) 1.17
Sustained pharmacological inhibition of deltaPKC protects against hypertensive encephalopathy through prevention of blood-brain barrier breakdown in rats. J Clin Invest (2008) 1.17
Peptides derived from the C2 domain of protein kinase C epsilon (epsilon PKC) modulate epsilon PKC activity and identify potential protein-protein interaction surfaces. J Biol Chem (2006) 1.16
Sequential activation of individual PKC isozymes in integrin-mediated muscle cell spreading: a role for MARCKS in an integrin signaling pathway. J Cell Sci (2002) 1.14
Epsilon protein kinase C mediated ischemic tolerance requires activation of the extracellular regulated kinase pathway in the organotypic hippocampal slice. J Cereb Blood Flow Metab (2004) 1.14
deltaPKC participates in the endoplasmic reticulum stress-induced response in cultured cardiac myocytes and ischemic heart. J Mol Cell Cardiol (2007) 1.11
DeltaPKC mediates microcerebrovascular dysfunction in acute ischemia and in chronic hypertensive stress in vivo. Brain Res (2007) 1.11
Insight into intra- and inter-molecular interactions of PKC: design of specific modulators of kinase function. Pharmacol Res (2007) 1.10
Oxymatrine diminishes the side population and inhibits the expression of β-catenin in MCF-7 breast cancer cells. Med Oncol (2010) 1.10
Exercise training restores cardiac protein quality control in heart failure. PLoS One (2012) 1.06
A critical intramolecular interaction for protein kinase Cepsilon translocation. J Biol Chem (2004) 1.06
Protein kinase C delta (deltaPKC)-annexin V interaction: a required step in deltaPKC translocation and function. J Biol Chem (2006) 1.06
Protein quality control disruption by PKCβII in heart failure; rescue by the selective PKCβII inhibitor, βIIV5-3. PLoS One (2012) 1.05
Suppression of graft coronary artery disease by a brief treatment with a selective epsilonPKC activator and a deltaPKC inhibitor in murine cardiac allografts. Circulation (2004) 1.04
Dopamine and ethanol cause translocation of epsilonPKC associated with epsilonRACK: cross-talk between cAMP-dependent protein kinase A and protein kinase C signaling pathways. Mol Pharmacol (2008) 1.04
epsilonPKC confers acute tolerance to cerebral ischemic reperfusion injury. Neurosci Lett (2008) 1.04
Intracellular mechanisms of specific beta-adrenoceptor antagonists involved in improved cardiac function and survival in a genetic model of heart failure. J Mol Cell Cardiol (2008) 1.03
Protein kinase C delta cleavage initiates an aberrant signal transduction pathway after cardiac arrest and oxygen glucose deprivation. J Cereb Blood Flow Metab (2005) 1.03
Metabonomic evaluation of melamine-induced acute renal toxicity in rats. J Proteome Res (2010) 1.02
ALDH2 activator inhibits increased myocardial infarction injury by nitroglycerin tolerance. Sci Transl Med (2011) 1.02
Pharmacological inhibition of epsilon-protein kinase C attenuates cardiac fibrosis and dysfunction in hypertension-induced heart failure. Hypertension (2008) 1.02
Opposing effects of delta- and zeta-protein kinase C isozymes on cardiac fibroblast proliferation: use of isozyme-selective inhibitors. J Mol Cell Cardiol (2003) 1.00
Protein kinase C epsilon and gamma: involvement in formalin-induced nociception in neonatal rats. J Pharmacol Exp Ther (2004) 1.00
Pharmacological inhibition of βIIPKC is cardioprotective in late-stage hypertrophy. J Mol Cell Cardiol (2011) 0.99
RACK1 regulates Src-mediated Sam68 and p190RhoGAP signaling. Oncogene (2004) 0.98
Myocardial salvage in acute myocardial infarction--challenges in clinical translation. J Mol Cell Cardiol (2011) 0.98
Isozyme-specific inhibitors and activators of protein kinase C. Methods Enzymol (2002) 0.98
Exercise training prevents oxidative stress and ubiquitin-proteasome system overactivity and reverse skeletal muscle atrophy in heart failure. PLoS One (2012) 0.98
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) phosphorylation by protein kinase Cδ (PKCδ) inhibits mitochondria elimination by lysosomal-like structures following ischemia and reoxygenation-induced injury. J Biol Chem (2013) 0.97
deltaPKC inhibition or varepsilonPKC activation repairs endothelial vascular dysfunction by regulating eNOS post-translational modification. J Mol Cell Cardiol (2009) 0.97
Compound Kushen Injection suppresses human breast cancer stem-like cells by down-regulating the canonical Wnt/β-catenin pathway. J Exp Clin Cancer Res (2011) 0.97
A personalized medicine approach for Asian Americans with the aldehyde dehydrogenase 2*2 variant. Annu Rev Pharmacol Toxicol (2014) 0.97
Centrosomal PKCbetaII and pericentrin are critical for human prostate cancer growth and angiogenesis. Cancer Res (2008) 0.96
A novel aldehyde dehydrogenase-3 activator leads to adult salivary stem cell enrichment in vivo. Clin Cancer Res (2011) 0.96
Molecular dynamics characterization of the C2 domain of protein kinase Cbeta. J Biol Chem (2002) 0.96
[Influence of shenfu injection on heart function and bone marrow stem cell mobilization in patients with chronic heart failure of coronary heart disease]. Zhongguo Zhong Xi Yi Jie He Za Zhi (2009) 0.96
Image analysis for classification of dysplasia in Barrett's esophagus using endoscopic optical coherence tomography. Biomed Opt Express (2010) 0.96
Discovery of a novel class of covalent inhibitor for aldehyde dehydrogenases. J Biol Chem (2011) 0.95
Triptolide ameliorates IL-10-deficient mice colitis by mechanisms involving suppression of IL-6/STAT3 signaling pathway and down-regulation of IL-17. Mol Immunol (2010) 0.94
PKCβII inhibition attenuates myocardial infarction induced heart failure and is associated with a reduction of fibrosis and pro-inflammatory responses. J Cell Mol Med (2011) 0.94
Nitroglycerin use in myocardial infarction patients. Circ J (2011) 0.93
Sympathetic hyperactivity differentially affects skeletal muscle mass in developing heart failure: role of exercise training. J Appl Physiol (1985) (2009) 0.93
Highly Specific Modulators of Protein Kinase C Localization: Applications to Heart Failure. Drug Discov Today Dis Mech (2010) 0.92
Mast cells and epsilonPKC: a role in cardiac remodeling in hypertension-induced heart failure. J Mol Cell Cardiol (2008) 0.92
RBCK1, a protein kinase CbetaI (PKCbetaI)-interacting protein, regulates PKCbeta-dependent function. J Biol Chem (2006) 0.92
The puromycin route to assess stereo- and regiochemical constraints on peptide bond formation in eukaryotic ribosomes. J Am Chem Soc (2003) 0.91
MOVING BEYOND COLOR: THE CASE FOR MULTISPECTRAL IMAGING IN BRIGHTFIELD PATHOLOGY. Proc IEEE Int Symp Biomed Imaging (2009) 0.91
Paeoniflorin protects human EA.hy926 endothelial cells against gamma-radiation induced oxidative injury by activating the NF-E2-related factor 2/heme oxygenase-1 pathway. Toxicol Lett (2013) 0.91
Dynamic ensemble view of the conformational landscape of HIV-1 TAR RNA and allosteric recognition. Biochemistry (2011) 0.90
Impact of exercise training on redox signaling in cardiovascular diseases. Food Chem Toxicol (2013) 0.90
Cell-specific role for epsilon- and betaI-protein kinase C isozymes in protecting cortical neurons and astrocytes from ischemia-like injury. Neuropharmacology (2004) 0.90